# Oral Huzhang Granules for Acute Gouty Arthritis

> **NCT04462666** · PHASE2 · UNKNOWN · sponsor: **Shanghai Yueyang Integrated Medicine Hospital** · enrollment: 267 (estimated)

## Conditions studied

- Gouty Arthritis

## Interventions

- **DRUG:** Huzhang granule
- **DRUG:** Etoricoxib
- **DRUG:** Huzhang granule Placebo
- **DRUG:** Etoricoxib Placebo

## Key facts

- **NCT ID:** NCT04462666
- **Lead sponsor:** Shanghai Yueyang Integrated Medicine Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-07-01
- **Primary completion:** 2023-07-31
- **Final completion:** 2023-08-31
- **Target enrollment:** 267 (ESTIMATED)
- **Last updated:** 2020-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04462666

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04462666, "Oral Huzhang Granules for Acute Gouty Arthritis". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT04462666. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*